DHR [NYSE]
Danaher Corporation
IndexS&P 500 P/E28.59 EPS (ttm)8.52 Insider Own0.30% Shs Outstand716.30M Perf Week2.74%
Market Cap170.26B Forward P/E22.35 EPS next Y10.90 Insider Trans-4.76% Shs Float647.19M Perf Month-10.80%
Income6.21B PEG2.59 EPS next Q2.37 Inst Own79.90% Short Float0.68% Perf Quarter-9.00%
Sales30.28B P/S5.62 EPS this Y73.90% Inst Trans0.83% Short Ratio1.57 Perf Half Y-20.29%
Book/sh60.15 P/B4.05 EPS next Y5.44% ROA7.70% Target Price327.80 Perf Year-2.30%
Cash/sh5.32 P/C45.81 EPS next 5Y11.05% ROE15.30% 52W Range233.71 - 333.96 Perf YTD-25.96%
Dividend1.00 P/FCF26.61 EPS past 5Y22.50% ROI9.60% 52W High-25.11% Beta0.85
Dividend %0.41% Quick Ratio1.30 Sales past 5Y11.80% Gross Margin60.80% 52W Low7.01% ATR8.43
Employees78000 Current Ratio1.70 Sales Q/Q12.10% Oper. Margin24.90% RSI (14)45.30 Volatility2.70% 3.30%
OptionableYes Debt/Eq0.51 EPS Q/Q1.10% Profit Margin20.80% Rel Volume0.53 Prev Close243.60
ShortableYes LT Debt/Eq0.51 EarningsApr 21 BMO Payout9.60% Avg Volume2.81M Price250.09
Recom1.90 SMA20-0.28% SMA50-7.62% SMA200-15.56% Volume1,268,342 Change2.66%
Apr-25-22Downgrade Wells Fargo Overweight → Equal Weight $265
Jan-11-22Initiated Bernstein Outperform $365
Oct-15-21Resumed Cowen Outperform $350
Sep-10-21Reiterated BofA Securities Buy $340 → $360
Aug-05-21Resumed Credit Suisse Outperform $306
Jul-23-21Reiterated Goldman Buy $280 → $320
Jul-16-21Initiated The Benchmark Company Buy $330
Apr-07-21Resumed Robert W. Baird Outperform $249
Mar-03-21Resumed Barclays Overweight $260
Dec-02-20Initiated Goldman Buy $250
Nov-25-20Downgrade RBC Capital Mkts Outperform → Sector Perform $273 → $234
Nov-10-20Initiated KeyBanc Capital Markets Overweight $280
Jun-16-20Upgrade Wolfe Research Peer Perform → Outperform
Apr-02-20Downgrade Wolfe Research Outperform → Peer Perform $154
Mar-26-20Upgrade RBC Capital Mkts Sector Perform → Outperform $151 → $157
Feb-03-20Reiterated Needham Buy $167 → $187
Jan-08-20Initiated Wells Fargo Overweight $170
Jan-07-20Initiated Citigroup Buy $180
Nov-15-19Resumed Stifel Hold
Oct-28-19Reiterated Needham Buy $155 → $152
May-17-22 03:37PM  
May-13-22 09:02AM  
May-12-22 04:30PM  
May-10-22 04:15PM  
07:43AM  
May-09-22 03:01PM  
11:00AM  
May-08-22 09:17AM  
May-04-22 04:30PM  
May-02-22 03:25PM  
Apr-25-22 02:15PM  
Apr-21-22 12:00PM  
10:04AM  
07:24AM  
07:15AM  
06:00AM  
Apr-20-22 06:55AM  
Apr-19-22 11:52AM  
10:51AM  
10:49AM  
Apr-18-22 03:54PM  
Apr-12-22 04:30PM  
Apr-08-22 11:40AM  
Apr-07-22 08:56AM  
Apr-06-22 05:42PM  
Apr-04-22 03:19AM  
Mar-31-22 06:15PM  
Mar-28-22 09:00AM  
Mar-25-22 06:00PM  
01:15PM  
06:45AM  
Mar-24-22 06:15PM  
03:20PM  
12:30PM  
06:09AM  
Mar-23-22 05:20PM  
Mar-21-22 04:30PM  
08:55AM  
Mar-17-22 06:15PM  
02:03PM  
Mar-11-22 06:00PM  
Mar-10-22 06:15PM  
12:48PM  
12:17PM  
Mar-07-22 12:07PM  
Mar-04-22 06:00PM  
08:35AM  
Mar-03-22 11:40AM  
Mar-01-22 04:30PM  
Feb-23-22 04:15PM  
Feb-14-22 10:52AM  
Feb-10-22 04:44PM  
Feb-08-22 10:38AM  
Feb-07-22 05:38PM  
01:38PM  
09:38AM  
Feb-04-22 02:38PM  
Feb-03-22 01:38PM  
01:38PM  
08:15AM  
Feb-02-22 05:38PM  
03:06PM  
09:38AM  
09:38AM  
Feb-01-22 01:38PM  
09:38AM  
Jan-31-22 05:38PM  
01:38PM  
07:13AM  
Jan-28-22 08:42PM  
05:38PM  
Jan-27-22 01:38PM  
11:12AM  
07:15AM  
06:00AM  
Jan-26-22 10:52AM  
10:30AM  
Jan-25-22 01:38PM  
12:09PM  
11:54AM  
11:10AM  
10:29AM  
09:38AM  
09:38AM  
07:45AM  
Jan-24-22 05:38PM  
04:37PM  
02:48PM  
09:48AM  
09:38AM  
08:44AM  
Jan-21-22 05:38PM  
05:38PM  
01:38PM  
10:49AM  
10:00AM  
09:38AM  
Jan-20-22 09:38PM  
03:02PM  
09:38AM  
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RALES MITCHELL PChairman of Exec. CommitteeMay 16Buy247.8920049,5783,256May 17 04:20 PM
Weidemanis JoakimExecutive Vice PresidentApr 25Sale255.746,5001,662,27886,398Apr 27 05:05 PM
Ellis Brian WSenior Vice President - GCFeb 02Sale293.995,3651,577,24812,374Feb 03 05:06 PM
Weidemanis JoakimExecutive Vice PresidentJan 31Option Exercise46.1320,508946,03484,351Feb 02 05:04 PM
Weidemanis JoakimExecutive Vice PresidentJan 31Sale285.2420,5085,849,75363,843Feb 02 05:04 PM
Raskas DanielSVP - Corporate DevelopmentNov 30Option Exercise46.1312,294567,12234,538Dec 01 05:02 PM
Raskas DanielSVP - Corporate DevelopmentNov 30Sale326.0012,2944,007,84422,244Dec 01 05:02 PM
Lalor Angela SSVP, Human ResourcesNov 29Option Exercise65.8337,5132,469,48168,450Nov 30 05:10 PM
Zerhouni Elias A.DirectorNov 29Sale328.423,4091,119,59425,139Nov 30 05:13 PM
Lalor Angela SSVP, Human ResourcesNov 29Sale327.0037,51312,266,75130,937Nov 30 05:10 PM
Raskas DanielSVP - Corporate DevelopmentNov 26Option Exercise46.1312,300567,39934,850Nov 30 05:01 PM
McGrew MatthewEVP & Chief Financial OfficerNov 26Sale325.502,589842,7206,811Nov 30 05:06 PM
Raskas DanielSVP - Corporate DevelopmentNov 26Sale325.3312,3004,001,52222,550Nov 30 05:01 PM
HEFNER LINDA PDirectorNov 18Option Exercise43.928,038353,02752,024Nov 19 05:01 PM
HEFNER LINDA PDirectorNov 18Sale308.854,5481,404,62747,476Nov 19 05:01 PM
HEFNER LINDA PDirectorNov 11Sale303.722,185663,62843,986Nov 12 07:43 AM
Weidemanis JoakimExecutive Vice PresidentNov 10Sale297.555,0001,487,75065,720Nov 12 07:40 AM
RALES MITCHELL PChairman of Exec. CommitteeNov 04Sale305.99194,25759,440,6990Nov 04 06:42 PM
RALES MITCHELL PChairman of Exec. CommitteeNov 04Sale305.85343,862105,169,3731,181,366Nov 04 06:42 PM
RALES MITCHELL PChairman of Exec. CommitteeNov 03Sale307.35343,861105,686,7601,525,228Nov 04 06:42 PM
RALES MITCHELL PChairman of Exec. CommitteeNov 02Sale312.94343,861107,609,0731,869,089Nov 04 06:42 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerAug 13Option Exercise57.905,000289,50021,155Aug 17 05:22 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerAug 13Sale313.405,0001,567,00116,155Aug 17 05:22 PM
Weidemanis JoakimExecutive Vice PresidentJul 30Sale298.936,7002,002,81870,720Aug 02 05:03 PM
Ellis Brian WSVP and General CounselJul 28Option Exercise65.9512,000791,40033,334Jul 29 05:07 PM
McGrew MatthewEVP & Chief Financial OfficerJul 28Option Exercise46.1312,310567,86016,236Jul 29 05:02 PM
Ellis Brian WSVP and General CounselJul 28Sale291.0012,0003,492,00021,334Jul 29 05:07 PM
McGrew MatthewEVP & Chief Financial OfficerJul 28Sale293.4012,3103,611,7829,400Jul 29 05:02 PM
Weidemanis JoakimExecutive Vice PresidentJul 27Option Exercise40.459,467382,94086,887Jul 28 05:04 PM
Weidemanis JoakimExecutive Vice PresidentJul 27Sale289.4516,4674,766,43577,420Jul 28 05:04 PM
HEFNER LINDA PDirectorJul 26Option Exercise38.124,350165,82246,430Jul 28 05:03 PM
List TeriDirectorMay 27Option Exercise38.644,548175,73520,862May 28 04:46 PM
List TeriDirectorMay 27Sale255.104,5481,160,19516,314May 28 04:46 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerMay 21Sale254.756,0061,530,02816,155May 24 05:10 PM